Bangladesh
· Delayed Price · Currency is BDT Libra Infusions Statistics
Total Valuation
Libra Infusions has a market cap or net worth of BDT 2.40 billion.
| Market Cap | 2.40B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Libra Infusions has 2.25 million shares outstanding.
| Shares Outstanding | 2.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.16 |
| PB Ratio | 1.26 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 48.03.
| Current Ratio | 0.65 |
| Quick Ratio | 0.22 |
| Debt / Equity | 48.03 |
| Debt / EBITDA | 31.80 |
| Debt / FCF | -174.68 |
| Interest Coverage | 0.97 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on invested capital (ROIC) is 0.49%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 0.36% |
| Return on Capital (ROIC) | 0.49% |
| Revenue Per Employee | 281,876 |
| Profits Per Employee | 2,266 |
| Employee Count | 699 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +94.95% |
| 50-Day Moving Average | 807.21 |
| 200-Day Moving Average | 810.77 |
| Relative Strength Index (RSI) | 74.14 |
| Average Volume (20 Days) | 43,153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Libra Infusions had revenue of BDT 197.03 million and earned 1.58 million in profits. Earnings per share was 0.70.
| Revenue | 197.03M |
| Gross Profit | 77.89M |
| Operating Income | 22.22M |
| Pretax Income | 2.26M |
| Net Income | 1.58M |
| EBITDA | 28.79M |
| EBIT | 22.22M |
| Earnings Per Share (EPS) | 0.70 |
Balance Sheet
The company has 14.39 million in cash and 915.38 million in debt, giving a net cash position of -901.00 million or -399.93 per share.
| Cash & Cash Equivalents | 14.39M |
| Total Debt | 915.38M |
| Net Cash | -901.00M |
| Net Cash Per Share | -399.93 |
| Equity (Book Value) | 1.91B |
| Book Value Per Share | 845.97 |
| Working Capital | -104.18M |
Cash Flow
In the last 12 months, operating cash flow was 14.67 million and capital expenditures -19.91 million, giving a free cash flow of -5.24 million.
| Operating Cash Flow | 14.67M |
| Capital Expenditures | -19.91M |
| Free Cash Flow | -5.24M |
| FCF Per Share | -2.33 |
Margins
Gross margin is 39.53%, with operating and profit margins of 11.28% and 0.80%.
| Gross Margin | 39.53% |
| Operating Margin | 11.28% |
| Pretax Margin | 1.15% |
| Profit Margin | 0.80% |
| EBITDA Margin | 14.61% |
| EBIT Margin | 11.28% |
| FCF Margin | -2.66% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 0.58% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.09% |
| Earnings Yield | 0.07% |
| FCF Yield | -0.22% |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |